The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
The state animals of India have been chosen to highlight the wildlife diversity in India,…
Captain Smit Machchhar, an Indian pilot, has been awarded the First Class Order of Zayed…
According to the World Meteorological Organisation, CO₂, CH₄ and N₂O had increased to record levels…
The Karnataka all-round cricketer Uma Kashvi, who is also known by her maiden name Kashvi…
The Bihar Museum in Patna ranks ninth among all museums worldwide and first among all…
Neeraj Yadav, an Indian para-athlete from Ghaziabad, Uttar Pradesh has gained recognition after his success…